Frazis Capital Podcast
Latest Podcasts
Episode 48: SALT interview with Rachel Pether – true love and explosive growth
Michael Frazis describes his investment company’s strategy that involves a 30-40 year view, not panicking and diverting the approach during dips and rallies.
Episode 47: A disastrous decision from the FDA
Michael Frazis attempts to understand the FDA’s decision to approve Biogen’s aducanumab for Alzheimer’s and the possible ramifications.
Episode 46: Strategy in the Life Sciences
Timestamps 0:32 – Our fast-growing portfolio companies. 2:21 – Frazis life sciences strategy update. 5:18 – RNAi Biology
New Episodes Weekly
Live Every Thursday @ 9am
This Weeks Guest.
Robert Stretch, MD
Signup for Frazis Insights
Get monthly shareouts from the Frazis team, keep up to date on perspectives, interviews, features, spaces and more.